China Medical System Holdings Limited (OTCMKTS:CHSYF) Short Interest Update

China Medical System Holdings Limited (OTCMKTS:CHSYF) was the recipient of a significant decline in short interest during the month of September. As of September 30th, there was short interest totalling 204,800 shares, a decline of 25.2% from the September 15th total of 273,800 shares. Based on an average trading volume of 100 shares, the days-to-cover ratio is currently 2,048.0 days.

China Medical System Price Performance

CHSYF remained flat at $0.93 on Friday. China Medical System has a 52-week low of $0.93 and a 52-week high of $0.93. The firm’s 50 day simple moving average is $0.93 and its two-hundred day simple moving average is $0.97.

China Medical System Company Profile

China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People's Republic of China. The company's products include Plendil for the treatment of hypertension and stable angina pectoris; XinHuoSu for the treatment of acute heart failure; Deanxit for the treating mild-to-moderate depression, anxiety, and psychosomatic affections; Ursofalk for the treatment of cholesterol gallstones in the gallbladder, cholestatic liver disease, and biliary reflux gastritis; Salofalk for treating Ulcerative Colitis and Crohn's disease; Bioflor for the treatment of diarrhea; Combizym for dyspepsia; Augentropfen Stulln Mono eye drops to treat senile macula degeneration and asthenopia; and Hirudoid for blunt traumata with or without hematomas and superficial phlebitis insofar.